Cargando…
Cell type–specific labeling of newly synthesized proteins by puromycin inactivation
Puromycin and its derivative O-propargyl puromycin (OPP) have recently found widespread use in detecting nascent proteins. Use of these metabolic labels in complex mixtures of cells leads to indiscriminate tagging of nascent proteomes independent of cell type. Here, we show how a widely used mammali...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497999/ https://www.ncbi.nlm.nih.gov/pubmed/37543363 http://dx.doi.org/10.1016/j.jbc.2023.105129 |
_version_ | 1785105426486919168 |
---|---|
author | Cabrera-Cabrera, Florencia Tull, Helena Capuana, Roberta Kasvandik, Sergo Timmusk, Tõnis Koppel, Indrek |
author_facet | Cabrera-Cabrera, Florencia Tull, Helena Capuana, Roberta Kasvandik, Sergo Timmusk, Tõnis Koppel, Indrek |
author_sort | Cabrera-Cabrera, Florencia |
collection | PubMed |
description | Puromycin and its derivative O-propargyl puromycin (OPP) have recently found widespread use in detecting nascent proteins. Use of these metabolic labels in complex mixtures of cells leads to indiscriminate tagging of nascent proteomes independent of cell type. Here, we show how a widely used mammalian selection marker, puromycin N-acetyltransferase, can be repurposed for cell-specific metabolic labeling. This approach, which we named puromycin inactivation for cell-selective proteome labeling (PICSL), is based on efficient inactivation of puromycin or OPP in cells expressing puromycin N-acetyltransferase and detection of translation in other cell types. Using cocultures of neurons and glial cells from the rat brain cortex, we show the application of PICSL for puromycin immunostaining, Western blot, and mass spectrometric identification of nascent proteins. By combining PICSL and OPP-mediated proteomics, cell type–enriched proteins can be identified based on reduced OPP labeling in the cell type of interest. |
format | Online Article Text |
id | pubmed-10497999 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Society for Biochemistry and Molecular Biology |
record_format | MEDLINE/PubMed |
spelling | pubmed-104979992023-09-14 Cell type–specific labeling of newly synthesized proteins by puromycin inactivation Cabrera-Cabrera, Florencia Tull, Helena Capuana, Roberta Kasvandik, Sergo Timmusk, Tõnis Koppel, Indrek J Biol Chem Methods and Resources Puromycin and its derivative O-propargyl puromycin (OPP) have recently found widespread use in detecting nascent proteins. Use of these metabolic labels in complex mixtures of cells leads to indiscriminate tagging of nascent proteomes independent of cell type. Here, we show how a widely used mammalian selection marker, puromycin N-acetyltransferase, can be repurposed for cell-specific metabolic labeling. This approach, which we named puromycin inactivation for cell-selective proteome labeling (PICSL), is based on efficient inactivation of puromycin or OPP in cells expressing puromycin N-acetyltransferase and detection of translation in other cell types. Using cocultures of neurons and glial cells from the rat brain cortex, we show the application of PICSL for puromycin immunostaining, Western blot, and mass spectrometric identification of nascent proteins. By combining PICSL and OPP-mediated proteomics, cell type–enriched proteins can be identified based on reduced OPP labeling in the cell type of interest. American Society for Biochemistry and Molecular Biology 2023-08-04 /pmc/articles/PMC10497999/ /pubmed/37543363 http://dx.doi.org/10.1016/j.jbc.2023.105129 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Methods and Resources Cabrera-Cabrera, Florencia Tull, Helena Capuana, Roberta Kasvandik, Sergo Timmusk, Tõnis Koppel, Indrek Cell type–specific labeling of newly synthesized proteins by puromycin inactivation |
title | Cell type–specific labeling of newly synthesized proteins by puromycin inactivation |
title_full | Cell type–specific labeling of newly synthesized proteins by puromycin inactivation |
title_fullStr | Cell type–specific labeling of newly synthesized proteins by puromycin inactivation |
title_full_unstemmed | Cell type–specific labeling of newly synthesized proteins by puromycin inactivation |
title_short | Cell type–specific labeling of newly synthesized proteins by puromycin inactivation |
title_sort | cell type–specific labeling of newly synthesized proteins by puromycin inactivation |
topic | Methods and Resources |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497999/ https://www.ncbi.nlm.nih.gov/pubmed/37543363 http://dx.doi.org/10.1016/j.jbc.2023.105129 |
work_keys_str_mv | AT cabreracabreraflorencia celltypespecificlabelingofnewlysynthesizedproteinsbypuromycininactivation AT tullhelena celltypespecificlabelingofnewlysynthesizedproteinsbypuromycininactivation AT capuanaroberta celltypespecificlabelingofnewlysynthesizedproteinsbypuromycininactivation AT kasvandiksergo celltypespecificlabelingofnewlysynthesizedproteinsbypuromycininactivation AT timmusktonis celltypespecificlabelingofnewlysynthesizedproteinsbypuromycininactivation AT koppelindrek celltypespecificlabelingofnewlysynthesizedproteinsbypuromycininactivation |